Checklist Tool in Engaging Patients in the Discharge Planning Process (TEPID)

The Ohio State University

Status: Completed

Conditions: Malignant Neoplasm; Transitional Care Planning; Hospitalization

Treatments: Other: Questionnaire Administration; Other: Survey Administration; Other: Communication Intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT02942524

OSU-14237

NCI-2016-01308 (Registry Identifier)

Details and patient eligibility

About

This clinical trial studies how well a checklist tool works in engaging patients in the discharge planning process. Engaging patients in the discharge process may increase participation in the discharge process and improve discharge outcomes, understanding of care after hospitalization, and decrease complications.

Full description

PRIMARY OBJECTIVES:

I. Measure the impact on discharge and transition satisfaction of utilizing questions from the Consumer Assessment of Healthcare Providers and Systems (CHAPS) patient satisfaction survey.

II. Measure the impact of the Tool to Engage Patients in Discharge (TEPID) on patient's Readiness for Hospital Discharge and Problems After Discharge Questionnaire-English (PADQ-E) results.

III. Measure the impact on decreasing healthcare utilization measures: readmission rates within 30 days from hospital discharge, hospital length of stay of admission in hospital, and emergency department visits within 30 days of hospital discharge.

OUTLINE:

Patients complete the TEPID checklist of items during hospital stay.

After completion of the study, patients are followed up for 35 days.

Enrollment: 450 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients fluent in English, conscious, coherent, and alert or have an adult caregiver present that is fluent in English will be identified for the TEPID research project

Exclusion criteria

• Patients discharged to another inpatient facility (hospice, skilled nursing facility, long term acute care hospital [LTACH], or acute rehab) or patients discharged home with hospice will be excluded
• Any patients that are transferred to another unit prior to discharge will be excluded

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

450 participants in 1 patient group

Supportive care (TEPID)

Experimental group

Description:

Patients complete the TEPID checklist of items during hospital stay.

Treatment:

Other: Survey Administration

Other: Questionnaire Administration

Other: Communication Intervention